Evidence map›Paper›PMID 31832763›Full record

ArticleMycorrhiza2020

AM fungal diversity and its impact across three types of mid-temperate steppe in Inner Mongolia, China.

Qi Wang, Yuying Bao, Ji Nan, Daolong Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Mycorrhiza, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qi WangSchool of Life Sciences, Inner Mongolia University, Hohhot, 010070, People's Republic of China.
Yuying BaoSchool of Life Sciences, Inner Mongolia University, Hohhot, 010070, People's Republic of China. imubaoyy@163.com.
Ji NanSchool of Life Sciences, Inner Mongolia University, Hohhot, 010070, People's Republic of China.
Daolong XuSchool of Life Sciences, Inner Mongolia University, Hohhot, 010070, People's Republic of China.

Funding

Health and Family Scientific Research Project of Inner Mongolia Autonomous Region 201703129National Natural Science Foundation of China 30760157National Natural Science Foundation of China 31760005Science Research Project of Inner Mongolia Autonomous Region 2017BS0804
6 · The paper itself

Abstract

Arbuscular mycorrhizal (AM) fungal diversity was measured in three different natural mid-temperate steppe types: the meadow steppe, typical steppe, and desert steppe. In these steppe soils, 24 AM fungal species from eight genera were identified, in which Glomus had the highest relative abundance. Funneliformis geosporus, Glomus microaggregatum, and Septoglomus constrictum had high relative abundance and were found widely across varying soil depth and steppe type. Meadow steppes had significantly higher AM fungal species richness compared to typical steppes and desert steppes, but there was no significant difference between typical steppes and desert steppes. AM fungal spore density, two Bradford-reactive soil protein (BRSP) fractions, and extraradical hyphal length densities (HLDs) were significantly different among the three steppe types. Alkaline phosphatase and acid phosphatase activity, urease activity, and soil bacterial and actinomycotic quantity were significantly related to the AM fungal spore density and species richness in these arid and semi-arid steppes. Therefore, steppe types could influence the distribution pattern of AM fungal diversity and the content of glomalin-related soil protein (GRSP).

Indexed as

MycorrhizaeChinaSoilSoil MicrobiologySpores, FungalSoilArbuscular mycorrhizal fungiDesert steppeGlomalin-related soil proteinMeadow steppeTypical steppe

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.